Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Pre-Commercial Procurement · Running

THERESA PCP Pre-Comercial Procurement of innovative and sustainable solutions to Treat HEalthcaRE System wAstewater

Coordinator
Fundacion Publica Miguel Servet, Spain
Runs
1 September 2025 to 31 August 2029
Status
Running
EU funding
€5.3m
Total cost
€5.3m
Partners
17 organisations in 6 countries
Type
Pre-Commercial Procurement
Grant agreement
101226565

What the project is doing

In the project's own words, from its summary on CORDIS.

Hospital wastewater (HWW) poses a significant environmental and health risk due to the presence of pharmaceuticals, pathogens, and other hazardous substances that are administered in healthcare institutions. Unfortunately, current urban wastewater treatment (WWT) plants are not capable of effectively removing many of the pollutants generated by hospitals. As a result, these contaminants reach and accumulate in natural water bodies, threatening ecosystems and biodiversity, and public health through the contamination of drinking water or food.

In addition, public health is also menaced by HWW as it contains important amounts of antibiotic-resistant microorganisms and genes. In fact, Antimicrobial Resistance (AMR) is one of the greatest health threats of our times. While most common medicines are consumed in households, specialized drugs such as cytostatic drugs, some antibiotics, or X-ray contrast agents are mainly distributed in hospitals. Furthermore, HWW is a hotspot for the transmission of antibiotic-resistant bacteria (ARB) and antibiotic-resistant genes (ARG).

To reduce the risk associated to these contaminants, it is key to remove them as close to their source as possible, and before they are discharged to the municipal water network. Despite the existence of different technologies that efficiently remove contaminants from HWW, currently, there is no single process that can be used for the comprehensive treatment of HWW regarding the elimination of a mix of pollutants to a high degree.

Moreover, technology may be further developed to be more efficient, environmentally sustainable, and cost-effective for hospitals. In this context, the main objective of THERESA PCP is to launch a pre-commercial procurement process (PCP) based on the development of an environmentally sustainable on-site system to decontaminate HWW, being capable of effectively removing, among other contaminants, cytostatic drugs, X-ray contrast agents, antibiotics, ARB and ARG, from HWW.

Topics

Who is involved

OrganisationCityCountryRole
Fundacion Publica Miguel ServetPamplonaSpainCoordinator
Health Care Without Harm EuropeBruxelles / BrusselBelgiumParticipant
Ziekenhuis Aan De StroomAntwerpenBelgiumParticipant
Sihtasutus Pohja-Eesti RegionaalhaiglaTallinnEstoniaParticipant
Corvers Greece Monoprosopi IkeAthensGreeceThird party
Consorci Hospitalari De VicVicSpainParticipant
Corvers Iberia SLZaragozaSpainThird party
Fundacion Publica Andaluza Progreso Y Salud M.p.SevillaSpainParticipant
Science & Innovation Link Office SLMadridSpainParticipant
Science Union for InnovationSevillaSpainParticipant
Servicio Andaluz De SaludSevillaSpainThird party
Ticbiomed Tecnologias De La Informacion Para La Salud En La Region De Murcia AsociacionMurciaSpainParticipant
Academisch Ziekenhuis MaastrichtMaastrichtNetherlandsParticipant
Corvers Procurement Services BVDen DungenNetherlandsParticipant
Universiteit MaastrichtMaastrichtNetherlandsThird party
Instytut Ekologii Terenow UprzemyslowionychKatowicePolandParticipant
Wojewodzki Szpital Specjalistyczny W OlsztynieOlsztynPolandParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI